There are 449 resources available
146P - Inter-fraction variation of internal target volume of lung tumour with 4D CT and 4D kV CBCT
Presenter: Karthick raja
Session: Poster Display session
147P - Population-adjusted indirect comparisons of repotrectinib and entrectinib in ROS1+ locally advanced or metastatic non-small cell lung cancer (NSCLC)
Presenter: Jurgen Wolf
Session: Poster Display session
148P - Neoadjuvant EGFR-TKI combined with chemotherapy improves the complete response rate in operable EGFR-mutant NSCLC patients: A multicenter real-world study
Presenter: WANPU YAN
Session: Poster Display session
149P - POSITION: Characterising risk factors and outcomes in patients (pts) with stage III unresectable non-small cell lung cancer (uNSCLC) who fail to complete concurrent chemoradiotherapy (cCRT) or progress during or shortly after cCRT
Presenter: Giannis Mountzios
Session: Poster Display session
150P - Cardioimaging in stage III lung cancer patients undergoing chemoRT: Preliminary CARERT results
Presenter: Federico Gagliardi
Session: Poster Display session
151P - Myocardial strain evaluation with cardiovascular MRI in patients with locally-advanced NSCLC treated with chemotherapy and radiation therapy
Presenter: Miguel García Pardo de Santayana
Session: Poster Display session
152P - Treatment (tx) patterns and clinical outcomes in unresectable stage III epidermal growth factor receptor-mutation positive (EGFRm) non-small cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT): Interim analysis of a global real-world (RW) study
Presenter: Joel Neal
Session: Poster Display session
153P - Evaluation of chemoradiotherapy-induced radiation pneumonia in non-small cell lung cancer patients with a history of the human coronavirus disease 2019 (COVID-19)
Presenter: Ulviyya Nabizade
Session: Poster Display session
154P - Five-year survival and safety outcomes from the START-NEW-ERA non-randomised phase II trial
Presenter: Fabio Arcidiacono
Session: Poster Display session
155P - Outcomes in patients with resectable stage III NSCLC who did not have definitive surgery after neoadjuvant treatment: Retrospective analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14
Presenter: Sabine Almeida
Session: Poster Display session